Hints and tips:
...Hassan was chairman and chief executive of Schering–Plough Corporation from 2003 to 2009....
...Schering-Plough, taken over last year by Merck, has recently announced a significant cut in headcount at its Brinny factory....
...Corporations that cut costs and hoarded cash during the financial crisis are acquiring their competitors to make up for lost time....
...Jacynthe Côté, Rio Tinto Alcan CEOSince 2009, previously Alcan Primary Metals from 2007 Carrie Cox, Schering-Plough Global Pharmaceuticals President and EVP Betty Deng, Deutsche Bank China, Chief country...
...The 2007 bids for Reuters and Dow Jones, by Thomson Corporation and News Corp, respectively, raised expectations of further consolidation among information providers, but finance for such deals dried up...
...Schering-Plough picked up 14.2 per cent to $20.13....
...Morgan Stanley ranked first in global announced M&A in the first quarter,6 and has advised on most of the major deals so far this year, including Pfizer/Wyeth, Merck/Schering-Plough and Rio Tinto/Aluminum...
...Merck also rose after it said it would issue a $1bn bond ahead of its planned $41bn takeover of rival Schering-Plough. Its shares climbed 2.6 per cent to $26.72....
...The results came in spite of the loss of patent protection for Fosamax, an osteoporosis treatment, as well as a decline in expected sales from the company’s joint venture in cholestorol drugs with Schering-Plough...
...Under Ho, who holds a masters degree in electrical engineering from Stanford University, Temasek has bought stakes in China Construction Bank Corporation and Bank of China....
...The healthcare sector was in focus after results from WellPoint, the health insurer, and drugmaker Schering-Plough....
...The lonely little stand taken by Bayer Schering Pharma was dwarfed by the space occupied by the happy paddlers of the Boating Alliance....
...AstraZeneca added 2.9 per cent to £22.89 on further rumours of a tie-up with Schering Plough....
...Drugmakers Schering-Plough and Merck gained 10.3 per cent to $18.61 and 2.3 per cent to $40.94 respectively after posting better-than-expected results....
...FT: Tougher than running a corporation? MR SMITH: I don’t think it’s tougher, I think it’s different. FT: But if you were asked?...
...Klaus Kleinfeld on Thursday unveiled the largest acquisition in his 15 months as chief executive of Siemens as the German conglomerate agreed to buy Diagnostics Products Corporation for $1.9bn to strengthen...
...The broker said dollar concerns and the Elan Antegren data release are likely to dampen enthusiasm for Schering shares from current levels, pointing out that Schering “has been a stunning performer so far...
...Schering, which markets the MS drug Betaseron and was hit on Monday by bullish news on Elan Corporation's Antegen drug, staged a modest rally, edging up 1.2 per cent to €49.31, helped by bullish comments...
...More announcements are likely, given that the legislation was sponsored by 13 trade associations and 57 corporations, including the likes of Apple, Dell, Intel, Nike and Schering-Plough....
International Edition